202 related articles for article (PubMed ID: 34555175)
1. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
[TBL] [Abstract][Full Text] [Related]
2. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract][Full Text] [Related]
3. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.
Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM
J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149
[TBL] [Abstract][Full Text] [Related]
5. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors.
Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ
J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901
[TBL] [Abstract][Full Text] [Related]
6. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
Satomi K; Ichimura K; Shibahara J
Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
[TBL] [Abstract][Full Text] [Related]
9. The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
Pages M; Uro-Coste E; Colin C; Meyronet D; Gauchotte G; Maurage CA; Rousseau A; Godfraind C; Mokhtari K; Silva K; Figarella-Branger D; Varlet P; On Behalf Of The Renoclip-Loc Network
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803647
[TBL] [Abstract][Full Text] [Related]
10. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
Jaunmuktane Z; Capper D; Jones DTW; Schrimpf D; Sill M; Dutt M; Suraweera N; Pfister SM; von Deimling A; Brandner S
Acta Neuropathol Commun; 2019 Feb; 7(1):24. PubMed ID: 30786920
[TBL] [Abstract][Full Text] [Related]
11. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
[TBL] [Abstract][Full Text] [Related]
12. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR
J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472
[TBL] [Abstract][Full Text] [Related]
13. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool.
Priesterbach-Ackley LP; Boldt HB; Petersen JK; Bervoets N; Scheie D; Ulhøi BP; Gardberg M; Brännström T; Torp SH; Aronica E; Küsters B; den Dunnen WFA; de Vos FYFL; Wesseling P; de Leng WWJ; Kristensen BW
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):478-492. PubMed ID: 32072658
[TBL] [Abstract][Full Text] [Related]
14. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.
Capper D; Stichel D; Sahm F; Jones DTW; Schrimpf D; Sill M; Schmid S; Hovestadt V; Reuss DE; Koelsche C; Reinhardt A; Wefers AK; Huang K; Sievers P; Ebrahimi A; Schöler A; Teichmann D; Koch A; Hänggi D; Unterberg A; Platten M; Wick W; Witt O; Milde T; Korshunov A; Pfister SM; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):181-210. PubMed ID: 29967940
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
Tam OCH; Ho RSL; Chan S; Li KKW; Lam TL; Cheung ETY; Cheung OY; Ho WWS; Cheng KKF; Shing MMK; Ku DTL; Chung BHY; Yang W; Chan GCF; Ng HK; Liu APY
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835574
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based classification of central nervous system tumours.
Capper D; Jones DTW; Sill M; Hovestadt V; Schrimpf D; Sturm D; Koelsche C; Sahm F; Chavez L; Reuss DE; Kratz A; Wefers AK; Huang K; Pajtler KW; Schweizer L; Stichel D; Olar A; Engel NW; Lindenberg K; Harter PN; Braczynski AK; Plate KH; Dohmen H; Garvalov BK; Coras R; Hölsken A; Hewer E; Bewerunge-Hudler M; Schick M; Fischer R; Beschorner R; Schittenhelm J; Staszewski O; Wani K; Varlet P; Pages M; Temming P; Lohmann D; Selt F; Witt H; Milde T; Witt O; Aronica E; Giangaspero F; Rushing E; Scheurlen W; Geisenberger C; Rodriguez FJ; Becker A; Preusser M; Haberler C; Bjerkvig R; Cryan J; Farrell M; Deckert M; Hench J; Frank S; Serrano J; Kannan K; Tsirigos A; Brück W; Hofer S; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Hans V; Rozsnoki S; Hansford JR; Kohlhof P; Kristensen BW; Lechner M; Lopes B; Mawrin C; Ketter R; Kulozik A; Khatib Z; Heppner F; Koch A; Jouvet A; Keohane C; Mühleisen H; Mueller W; Pohl U; Prinz M; Benner A; Zapatka M; Gottardo NG; Driever PH; Kramm CM; Müller HL; Rutkowski S; von Hoff K; Frühwald MC; Gnekow A; Fleischhack G; Tippelt S; Calaminus G; Monoranu CM; Perry A; Jones C; Jacques TS; Radlwimmer B; Gessi M; Pietsch T; Schramm J; Schackert G; Westphal M; Reifenberger G; Wesseling P; Weller M; Collins VP; Blümcke I; Bendszus M; Debus J; Huang A; Jabado N; Northcott PA; Paulus W; Gajjar A; Robinson GW; Taylor MD; Jaunmuktane Z; Ryzhova M; Platten M; Unterberg A; Wick W; Karajannis MA; Mittelbronn M; Acker T; Hartmann C; Aldape K; Schüller U; Buslei R; Lichter P; Kool M; Herold-Mende C; Ellison DW; Hasselblatt M; Snuderl M; Brandner S; Korshunov A; von Deimling A; Pfister SM
Nature; 2018 Mar; 555(7697):469-474. PubMed ID: 29539639
[TBL] [Abstract][Full Text] [Related]
17. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.
Pratt D; Sahm F; Aldape K
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S16-S29. PubMed ID: 34725697
[TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults.
Shi ZF; Li KK; Huang QJ; Wang WW; Kwan JS; Chen H; Liu XZ; Li WC; Chan DT; Zhang ZY; Mao Y; Ng HK
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12802. PubMed ID: 35191072
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
